Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Samsung Electronics America Inc.

www.samsung.com

Latest From Samsung Electronics America Inc.

Digital Health Roundup: Voice Biomarkers; SXSW, LSI, ACC; FTC BetterHelp Settlement

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses conference highlights from SXSW and LSI while Barnaby Pickering talks about his coverage on voice biomarkers. Hannah Daniel discusses BetterHelp’s return of $7.8m to customers to settle with FTC for sharing health data.

Digital Health Artificial Intelligence

FDA Codifies Down-Classification For Devices Such As The Apple Watch ECG App

The agency has codified its over-the-counter ECG software class II classification, which means sponsors can continue to benefit from filing for such apps through the less burdensome 510(k) pathway.

Regulation Policy

Eko Raises $65M In Series C Round To Expand AI-Based Digital Stethoscope For At-Home Patient Monitoring

Eko is banking on the growing telehealth market and reimbursement to expand its cardiac care platform.

Digital Health Financing

Fitbit Has OTC Electrocardiogram App To Rival Apple, Samsung With Clearance In US, EU

Fitbit will launch its new Fitbit Sense smartwatch with ECG app in Europe, US, Hong Kong and India in October. 

Approvals FDA
See All

Company Information

  • Industry
  • Diversified
UsernamePublicRestriction

Register